Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose erythropoietin after out-of-hospital cardiac arrest (EPO-ACR 02)
2009-011404-34Phase 3Active
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Apr 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial of epoetin alfa in cardiac arrest (SCA) and post-cardiac arrest syndrome (PCAS) (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Neurological outcome at day 60. Started Apr 2009; status: active.
02
Drugs
epoetin alfa
03
Conditions
cardiac arrest (SCA)post-cardiac arrest syndrome (PCAS)
Beyond the preview
Go deeper on 2009-011404-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011404-34.